A critical issue around COVID-19 has been detection and decreasing the amount of time required from the time the test is taken and getting results. One method that is being researched is the use of Polymerase Chain Reaction PCR, where the genetic material of the virus is replicated exponentially in order to enhance detection. This method, among others, generally takes significant time to generate results. What many scientists are exploring now are more novel methods that could provide faster detection and potentially lead to in-home testing.
Grants can provide insights as to the government organizations that are currently funding research at specific institutions, as well as state of the art advancements associated with the technologies. Using the ResoluteAI platform, we can generate search results from multiple datasets.
The graphic below shows both the governmental organizations that are sponsoring genetic detection of COVID-19, as well as the institutions that have received grants in this area:
Investigating the results further, specifically the work being done at the University of Maryland, we find that a novel method is being proposed for a rapid home test. The abstract of the work is displayed directly on ResoluteAI’s Foundation platform:
From the platform, the link to the external source is available.
Given that rapid detection of COVID is an important issue in slowing the spread, another interesting source of data is the work being conducted at research institutions independently, and published on technology transfer office (TTO) sites, where data from more than 300 of these institutions have been aggregated into Foundation. Searching specifically for rapid detection of COVID, we can find three results around rapid detection that provide potential licensing and/or co-development opportunities for corporate entities:
Here, a particularly interesting result from Wayne State University, which discussed alternative methods to PCR based on nano-technology:
Foundation allows a user to explore search results across disparate datasets based on the same search criteria. Using the same search used for finding TTO related research, a user can see any clinical trials that are related to this technology. Moving to the Clinical Trials dataset:
Here we see there are five clinical trials related to rapid detection technologies.
Below we have expanded the result from Huashan Hospital, which is working on a system that's able to rapidly detect a panel of 22 different pathogens, which - if a patient tests negative for COVID - provides additional data as to which pathogen is causing the symptoms being presented.
The results above show the capabilities of the ResoluteAI platform to discover the latest information in highly specific areas, enabling researchers to collaborate, and leverage new discoveries, as well as understand current clinical trials of new technology, and see where government funded research is occurring.